Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001254 · ClinicalTrials.gov registry record
Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome
A clinical trial, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- 273
- Enrollment target
NCT00001254 is a clinical trial that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 273 participants.
The verdict
NCT00001254 has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- 273 participants
- Enrollment target
Study Summary
This protocol concerns the approach to the localization, diagnosis of MEN1 and management of the tumor and the tissue samples in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor, investigations for MEN1 the subsequent management of the tumor and tissue samples for research....
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 273 participants |
| Start Date | 1991-10-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001254
The ClinicalTrials.gov registry entry for NCT00001254 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 273 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00001254 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001254 about?
NCT00001254 is a clinical study titled "Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome". This protocol concerns the approach to the localization, diagnosis of MEN1 and management of the tumor and the tissue samples in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor, investigations for MEN1 the subsequent management of th...
What is the current status of trial NCT00001254?
This trial is currently completed. The enrollment target is 273 participants. The study started on 1991-10-29.
Who is sponsoring clinical trial NCT00001254?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.